QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Gustaf Ortsäter at European Hepatitis C Inventory workshop
Gustaf Ortsäter will attend the European Hepatitis C Inventory workshop – From theory to action, arranged by the European Liver Patient Association in Brussels on the 11th of June. Gustaf will present an economic model of the burden of Hepatitis C in Romania and take part in round table discussion about the ongoing policy initiatives concerning Hepatitis C.
The Swedish National Board of Health and Welfare publishes report co-authored by Anders Gustavsson
The Swedish National Board of Health and Welfare (Socialstyrelsen) has published a report on the costs of dementia in 2012, co-authored by Anders Gustavsson. The costs of dementia are estimated at 63 billion SEK (~7 billion EUR) in 2012, in an estimated 158 thousand persons with dementia. The total costs are increasing over time due to the aging of the population resulting in more persons living with the disease. […]
Jonas Banefelt and Johan Mesterton published in Cancer Epidemiology
The article “Survival and clinical metastases among prostate cancer patients treated with androgen deprivation therapy in Sweden” has been published electronically ahead of print in Cancer Epidemiology. Jonas Banefelt and Johan Mesterton of Quantify Research are among the authors of the article. Pubmed link
Gylfi Olafsson to present poster at the ISPOR 19th Annual International Meeting
Gylfi Olafsson will be presenting a poster on an economic model of spinal disease at the ISPOR 19th Annual International Meeting, held between May 31st and June 4th in Montreal, Canada.